We are live on ! Find out more

Brookfield Real Assets Income Fund

RA

Market cap $649M

11.75 USD

+0.13

1.12%

At close Updated Oct 29, 4:00 PM EDT

1 day

1.12%

5 days

0.86%

1 month

1.21%

3 months

-7.84%

6 months

-8.84%

Year to date

-9.2%

1 year

-10.98%

5 years

-46.47%

10 years

-47.38%

About: Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. The investment objective of the Fund is to seek high total return, through high current income and secondarily, through growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities, Infrastructure Securities, and Natural Resources Securities. The Fund operates in a single operating segment.

Employees: 1,200

Financials Asset Management

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

Brookfield Real Assets Income Fund Beat JNK But 13% Yield Is Unsustainable

Brookfield Real Assets Income Fund Inc. delivers high monthly yields via leveraged, high-yield fixed income exposure in real assets but suffers persistent NAV erosion. RA's double-digit yield is not covered by portfolio income, resulting in a significant return of capital and long-term NAV decline since inception. There is one positive that prevents us from putting a Sell on this.

Brookfield Real Assets Income Fund Beat JNK But 13% Yield Is Unsustainable

Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule

NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund's monthly distributions for October, November and December 2026.

Brookfield Real Assets Income Fund Inc. Declares Q4 2026 Distribution Schedule

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--LAPIX Therapeutics has appointed Abbas Kazimi, Chief Executive Officer of Nimbus Therapeutics, to its Board of Directors as the Company advances its TIM 3/4 agonist program through Phase 1b clinical trials in rheumatoid arthritis (RA) and atopic dermatitis (AD). Kazimi brings more than two decades of biotechnology leadership experience spanning company building, corporate strategy, financing, and drug development. As CEO of Nimbus Therapeutics, he has overseen.

LAPIX Therapeutics Appoints Nimbus CEO Abbas Kazimi to Board of Directors

RA: A Classic Fixed-Income CEF In 'Real Assets' Clothing

Brookfield Real Assets Income Fund is a fixed income CEF, not a direct real assets holder, despite its name. RA primarily invests in corporate and securitized credit, with only 7.9% in equities and no direct commodity or real estate exposure. The fund's 10% distribution is supported by significant return of capital (~30%), with true cash flow yield closer to 7%.

RA: A Classic Fixed-Income CEF In 'Real Assets' Clothing

Brookfield Real Assets Income Fund Inc. Declares Q3 2026 Distribution Schedule

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund's monthly distributions for July, August and September 2026.

Brookfield Real Assets Income Fund Inc. Declares Q3 2026 Distribution Schedule

Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change

NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (the “Fund”) (NYSE: RA) today announced upcoming portfolio management changes at Oaktree Fund Advisors, LLC (“Oaktree”), the sub-adviser responsible for managing the Fund's securitized credit allocation.

Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change

RA: NAV Erosion Will Continue Even When Interest Rates Decline

Brookfield Real Assets Income Fund maintains a high 10.9% yield but suffers from persistent NAV erosion due to unsustainable dividend payouts. RA's net investment income consistently fails to cover distributions, forcing reliance on net realized gains and return of capital, which undermines NAV stability. The fund's heavy allocation to below-investment-grade, floating-rate credit and use of leverage heighten risk, especially in a high-rate environment.

RA: NAV Erosion Will Continue Even When Interest Rates Decline

Brookfield Real Assets Income Fund Inc. Declares Q2 2026 Distribution Schedule

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board of Directors (the “Board”) declared the Fund's monthly distributions for April, May and June 2026. Q2 2026 Distribution Schedule Month Record Date Ex-Dividend Date Payable Date Amount per Share April 2026 April 9, 2026 April 9, 2026 April 23, 2026 $0.1180 May 2026 May 7, 2026 May 7, 2026 May 21, 2026 $0.1180 June 2026 June 11, 2026 June 11, 2026 June 25, 2026 $0.1180 Shares purchased on or after the applicable ex-distribution dates will not receive the distributions discussed above.

Brookfield Real Assets Income Fund Inc. Declares Q2 2026 Distribution Schedule

Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change

NEW YORK, March 06, 2026 (GLOBE NEWSWIRE) -- Brookfield Public Securities Group LLC today announced an upcoming change to the Brookfield Real Assets Income Fund Inc. (the “Fund”) (NYSE: RA) portfolio management team. Effective June 30, 2026, Paula Horn will no longer serve as a Co-Portfolio Manager to the Fund.

Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change

RA: 10% Yield Not As Good As It Looks

Brookfield Real Assets Income Fund offers a tempting 10.88% yield but faces structural weaknesses, leading me to rate it Hold. RA's portfolio is heavily leveraged and concentrated in below-investment-grade fixed income tied to real estate and infrastructure, amplifying both yield and risk. The fund trades at a 10% NAV discount, but persistent low coupons and high expenses limit upside and reinvestment potential.

RA: 10% Yield Not As Good As It Looks

See News Rankings

Price charts implemented using Lightweight Charts™